ストックスクリーナーアプリを入手
9.485
3.98%
-0.455
前日終値:
$9.94
開ける：
$9.88
24時間の取引高:
19,432
Relative Volume:
0.12
時価総額：
$315.60M
収益：
$65.42M
当期純損益:
$-32.96M
株価収益率:
-7.4685
EPS:
-1.27
ネットキャッシュフロー:
$-19.87M
1週間 パフォーマンス:
-9.96%
1か月 パフォーマンス:
-12.60%
6か月 パフォーマンス:
-20.33%
1年 パフォーマンス:
+51.74%
1日の値動き範囲:
$9.53
$9.88
1週間の範囲:
$9.53
$10.81
52週間の値動き範囲:
$6.03
$18.98
Neuropace Inc Stock (NPCE) Company Profile
NPCE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NPCE
Neuropace Inc
|
9.54 | 328.83M | 65.42M | -32.96M | -19.87M | -1.27 |
|
ABT
Abbott Laboratories
|
122.67 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.22 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.39 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.16 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
80.47 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Neuropace Inc Stock (NPCE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-28 | 開始されました | H.C. Wainwright | Buy |
| 2025-01-21 | 開始されました | UBS | Buy |
| 2024-03-14 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | 開始されました | Leerink Partners | Outperform |
| 2023-11-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-08-24 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2023-02-22 | 開始されました | Lake Street | Buy |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-01-19 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-01-07 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-11 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-18 | 開始されました | Robert W. Baird | Outperform |
| 2021-05-17 | 開始されました | JP Morgan | Overweight |
| 2021-05-17 | 開始されました | Morgan Stanley | Overweight |
| 2021-05-17 | 開始されました | SVB Leerink | Outperform |
| 2021-05-17 | 開始されました | Wells Fargo | Overweight |
すべてを表示
Neuropace Inc (NPCE) 最新ニュース
NeuroPace Inc (NPCE) Q3 2025 Earnings Report Preview: What to Look For - Yahoo Finance
What technical signals suggest for NeuroPace Inc. stockMarket Sentiment Report & AI Based Trade Execution Alerts - newser.com
Why NeuroPace Inc. stock is a value investor pickEarnings Risk Report & Safe Swing Trade Setup Alerts - newser.com
Using RSI to spot recovery in NeuroPace Inc.CPI Data & Stock Market Timing Techniques - newser.com
Why NeuroPace Inc. stock is seen as undervaluedWeekly Investment Summary & Fast Exit and Entry Trade Guides - newser.com
Can NeuroPace Inc. stock sustain revenue growthJuly 2025 Gainers & Weekly Sector Rotation Insights - newser.com
Will NeuroPace Inc. stock recover faster than marketJuly 2025 Recap & Expert Approved Momentum Trade Ideas - newser.com
Tools to assess NeuroPace Inc.’s risk profilePortfolio Performance Report & Consistent Profit Focused Trading Strategies - newser.com
How to escape a deep drawdown in NeuroPace Inc.Rate Hike & Entry Point Strategy Guides - newser.com
Operating expenses (excl. COGS) of Neuropace, Inc. – BOATS:NPCE - TradingView
Will NeuroPace Inc. price bounce be sustainableTrade Entry Summary & Precise Buy Zone Identification - newser.com
Using data tools to time your NeuroPace Inc. exitEarnings Trend Report & Stepwise Entry and Exit Trade Signals - newser.com
Real time alert setup for NeuroPace Inc. performanceEntry Point & Long-Term Safe Return Strategies - newser.com
What is the fair value of NeuroPace Inc. stock now2025 Performance Recap & Advanced Swing Trade Entry Plans - newser.com
Evaluating NeuroPace Inc. with trendline analysisInflation Watch & Verified Stock Trade Ideas - newser.com
NeuroPace Inc. stock outlook for YEARTrade Volume Summary & High Win Rate Trade Alerts - newser.com
Can NeuroPace Inc. stock withstand economic slowdown2025 Valuation Update & High Yield Stock Recommendations - newser.com
Applying Elliott Wave Theory to NeuroPace Inc.Market Trend Summary & Consistent Profit Trade Alerts - newser.com
Will NeuroPace Inc. stock gain from government policiesMarket Risk Analysis & Smart Allocation Stock Reports - newser.com
Does NeuroPace Inc. fit your quant trading modelJuly 2025 Institutional & Real-Time Stock Movement Alerts - newser.com
Neuropace Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
Neuropace, Inc. (NPCE) Stock forecasts - Yahoo! Finance UK
Strategies to average down on NeuroPace Inc.Portfolio Profit Report & Smart Allocation Stock Tips - newser.com
Can NeuroPace Inc. stock resist market sell offsJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - newser.com
Can momentum traders help lift NeuroPace Inc.Market Sentiment Review & Technical Entry and Exit Alerts - newser.com
NeuroPace, Inc. Reports Record Revenue and Strong Margins in Q2 2025 Earnings Call - MSN
Neuropace Inc (NPCE) 財務データ
収益
当期純利益
現金流量
EPS
Neuropace Inc (NPCE) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Morrell Martha | CHIEF MEDICAL OFFICER |
Feb 21 '25 |
Sale |
13.72 |
78,334 |
1,074,844 |
81,993 |
| KCK LTD. | 10% Owner |
Feb 20 '25 |
Sale |
9.40 |
5,270,845 |
49,545,943 |
0 |
| Morrell Martha | CHIEF MEDICAL OFFICER |
Jan 30 '25 |
Sale |
15.00 |
200 |
3,000 |
86,762 |
| Morrell Martha | CHIEF MEDICAL OFFICER |
Jan 29 '25 |
Sale |
15.00 |
100 |
1,500 |
86,962 |
0.69%
0.27%
大文字化:
|
ボリューム (24 時間):